23/02/2026
Humacyte recently announced the presentation of 36-month data assessing the durability of its Symvess acellular tissue-engineered vessel in extremity arterial trauma patients.
Humacyte recently announced the presentation of 36-month data assessing the durability of Symvess in extremity arterial trauma patients.